Rotarix is given as a mouth drop and protects against the most common strains of the virus.

BBC: Babies born from May to be offered rotavirus vaccine

Testing of clinical samples conducted by GSK has not shown any indication of PCV-1 infection in infants who received Rotarix.

FORBES: Magazine Article

As a precautionary measure, on March 22, 2010, FDA recommended that US healthcare practitioners temporarily suspend the use of Rotarix.

FORBES: Magazine Article

The European Medicines Agency (EMA) and the World Health Organization (WHO) have not recommended any change to the way that healthcare practitioners in Europe and the developing world use Rotarix.

FORBES: Magazine Article

The FDA last March asked pediatricians to stop administering GlaxoSmithKline's Rotarix, a vaccine that prevents rotavirus infection, a diarrheal illness that commonly affects infants and children and that can cause severe dehydration.

FORBES: Magazine Article

The results of a trial of another oral vaccine called Rotarix, developed by GlaxoSmithKline, showed it was effective against the most common strain of rotavirus and able to prevent 85% of severe cases.

BBC: NEWS | Health | Diarrhoea vaccine tests 'hopeful'

Do they now rescind the Rotarix pause?

FORBES: Magazine Article